Advertisement

Fri, 20 Nov, 2026

Read Life Mag

Today’s Game

Daily Snakes and Ladders

12 mins play

Play now

Services & Opportunities

Latest news today on Molnupiravir

FILES-US-HEALTH-VIRUS-MERCK-EPIDEMIC
National

COVID-19 ‘miracle’ drug may halt craze for vaccine manufacturing

5 years ago

(FILES) This handout photo obtained May 26, 2021, courtesy of Pharmaceutical company Merck shows capsules of the experimental antiviral drug Molnupiravir. - Merck said on October 1, 2021, it will seek authorization in the US for molnupiravir for Covid-19, after the pill showed "compelling results" in a clinical trial. The experimental drug, significantly reduced the risk of hospitalization or death when administered to high-risk patients early in the disease, Merck and its partner Ridgeback Biotherapeutics said in a statement. (Photo by Handout / Merck & Co,Inc. / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /Merck & Co,Inc./HANDOUT" - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS

The Pharmaceutical Manufacturers Group of the Manufacturing Association of Nigeria (PMG-MAN) has hailed an experimental drug for severe COVID-19 that cuts the risk of hospitalisation or death by about half.

Advertisement